Rheumatoid Arthritis Completed Phase 4 Trials for Etanercept (DB00005)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00195377Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
NCT00565409Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid ArthritisTreatment
NCT00913458Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisTreatment
NCT00837434Anti-TNF Agents for the Treatment of Rheumatoid ArthritisTreatment
NCT01875991Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptTreatment
NCT01578850Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to ScreeningTreatment
NCT00099554Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)Treatment
NCT00094341Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesTreatment
NCT00115219Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)Treatment
NCT00132418Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersTreatment
NCT00422227Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionTreatment
NCT00195364Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
NCT00195494Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid ArthritisTreatment
NCT00688103Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in JapanTreatment
NCT00546533Study Evaluating the Efficacy and Safety of EtanerceptTreatment
NCT00654368CAMEO: Canadian Methotrexate and Etanercept Outcome StudyTreatment
NCT00848354Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) TherapyTreatment
NCT00858780Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RATreatment
NCT00484809Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
NCT00503503Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00768053Evaluation of EULAR-RAID Score in Rheumatoid Arthritis PatientsTreatment
NCT01331837A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk FactorsTreatment
NCT01295151SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.Treatment
NCT01313208Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)Treatment
NCT01021735Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic TherapyTreatment
NCT00252668Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsTreatment
NCT00259610Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)Treatment